Cargando…
Factor V Leiden G1691A and Prothrombin Gene G20210A Mutations on Pregnancy Outcome
Factor V Leiden (FVL) G1619A mutation and prothrombin gene (PTG) G20210A are the most common inherited thrombophilias. They have been associated with various obstetric complications such as venous thromboembolism, recurrent pregnancy loss, preeclampsia, abruptio placentae, and small for gestational...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8439407/ https://www.ncbi.nlm.nih.gov/pubmed/34540419 http://dx.doi.org/10.7759/cureus.17185 |
_version_ | 1783752519460061184 |
---|---|
author | Padda, Jaskamal Khalid, Khizer Mohan, Ayushi Pokhriyal, Sindhu Batra, Nitya Hitawala, Gazala Cooper, Ayden Charlene Jean-Charles, Gutteridge |
author_facet | Padda, Jaskamal Khalid, Khizer Mohan, Ayushi Pokhriyal, Sindhu Batra, Nitya Hitawala, Gazala Cooper, Ayden Charlene Jean-Charles, Gutteridge |
author_sort | Padda, Jaskamal |
collection | PubMed |
description | Factor V Leiden (FVL) G1619A mutation and prothrombin gene (PTG) G20210A are the most common inherited thrombophilias. They have been associated with various obstetric complications such as venous thromboembolism, recurrent pregnancy loss, preeclampsia, abruptio placentae, and small for gestational age fetus. The prevalence of these two mutations is 3-15% in Caucasians and is assumed to be far less common in other ethnic populations. However, there have been several controversies regarding advising routine screening of these thrombophilias because of a widely variable strength of association between different ethnic groups, as well as contradictory conclusions by different studies in regards to the association. In this study, the literature was analyzed thoroughly for the effect of FVL G1619A and PTG G20210A mutations on various obstetric outcomes. A review of multiple case-control and prospective studies suggests that despite the availability of robust data on this subject the results remain inconclusive and insubstantial. Further superior quality research, preferably prospective studies, is warranted to conclusively establish this relationship and to enable practitioners to follow a definitive protocol in the screening of various populations for these mutations to achieve an improved pregnancy outcome. |
format | Online Article Text |
id | pubmed-8439407 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-84394072021-09-16 Factor V Leiden G1691A and Prothrombin Gene G20210A Mutations on Pregnancy Outcome Padda, Jaskamal Khalid, Khizer Mohan, Ayushi Pokhriyal, Sindhu Batra, Nitya Hitawala, Gazala Cooper, Ayden Charlene Jean-Charles, Gutteridge Cureus Internal Medicine Factor V Leiden (FVL) G1619A mutation and prothrombin gene (PTG) G20210A are the most common inherited thrombophilias. They have been associated with various obstetric complications such as venous thromboembolism, recurrent pregnancy loss, preeclampsia, abruptio placentae, and small for gestational age fetus. The prevalence of these two mutations is 3-15% in Caucasians and is assumed to be far less common in other ethnic populations. However, there have been several controversies regarding advising routine screening of these thrombophilias because of a widely variable strength of association between different ethnic groups, as well as contradictory conclusions by different studies in regards to the association. In this study, the literature was analyzed thoroughly for the effect of FVL G1619A and PTG G20210A mutations on various obstetric outcomes. A review of multiple case-control and prospective studies suggests that despite the availability of robust data on this subject the results remain inconclusive and insubstantial. Further superior quality research, preferably prospective studies, is warranted to conclusively establish this relationship and to enable practitioners to follow a definitive protocol in the screening of various populations for these mutations to achieve an improved pregnancy outcome. Cureus 2021-08-15 /pmc/articles/PMC8439407/ /pubmed/34540419 http://dx.doi.org/10.7759/cureus.17185 Text en Copyright © 2021, Padda et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Internal Medicine Padda, Jaskamal Khalid, Khizer Mohan, Ayushi Pokhriyal, Sindhu Batra, Nitya Hitawala, Gazala Cooper, Ayden Charlene Jean-Charles, Gutteridge Factor V Leiden G1691A and Prothrombin Gene G20210A Mutations on Pregnancy Outcome |
title | Factor V Leiden G1691A and Prothrombin Gene G20210A Mutations on Pregnancy Outcome |
title_full | Factor V Leiden G1691A and Prothrombin Gene G20210A Mutations on Pregnancy Outcome |
title_fullStr | Factor V Leiden G1691A and Prothrombin Gene G20210A Mutations on Pregnancy Outcome |
title_full_unstemmed | Factor V Leiden G1691A and Prothrombin Gene G20210A Mutations on Pregnancy Outcome |
title_short | Factor V Leiden G1691A and Prothrombin Gene G20210A Mutations on Pregnancy Outcome |
title_sort | factor v leiden g1691a and prothrombin gene g20210a mutations on pregnancy outcome |
topic | Internal Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8439407/ https://www.ncbi.nlm.nih.gov/pubmed/34540419 http://dx.doi.org/10.7759/cureus.17185 |
work_keys_str_mv | AT paddajaskamal factorvleideng1691aandprothrombingeneg20210amutationsonpregnancyoutcome AT khalidkhizer factorvleideng1691aandprothrombingeneg20210amutationsonpregnancyoutcome AT mohanayushi factorvleideng1691aandprothrombingeneg20210amutationsonpregnancyoutcome AT pokhriyalsindhu factorvleideng1691aandprothrombingeneg20210amutationsonpregnancyoutcome AT batranitya factorvleideng1691aandprothrombingeneg20210amutationsonpregnancyoutcome AT hitawalagazala factorvleideng1691aandprothrombingeneg20210amutationsonpregnancyoutcome AT cooperaydencharlene factorvleideng1691aandprothrombingeneg20210amutationsonpregnancyoutcome AT jeancharlesgutteridge factorvleideng1691aandprothrombingeneg20210amutationsonpregnancyoutcome |